Dr. Crotty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-2106
Summary
- Erin Crotty, M.D. is an attending physician and pediatric oncologist in the Brain Tumor Program at Seattle Children's Hospital and an Assistant Professor at the University of Washington School of Medicine. She cares for children and young adults with brain and spinal cord tumors, and is the clinical oncology lead for the Retinoblastoma Program. She leads early phase clinical trials for children with brain tumors and serves as site Principal Investigator for the Pacific Pediatric Neuro-oncology Consortium (PNOC) and the Collaborative Network for Neuro-oncology Clinical Trials (CONNECT). Her clinical research focus is dedicated to bringing new therapies, including immunotherapies and precision medicine approaches, to young patients with difficult-to-treat central nervous system tumors. Dr. Crotty moderates Seattle Children’s weekly Brain Tumor Board, a platform for multidisciplinary review of patient cases offering tailored advice to providers and families on personalized treatment options and innovative clinical trials.
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 2017 - 2020
- George Washington University School of Medicine and Health SciencesClass of 2014, M.D.
Certifications & Licensure
- MT State Medical License 2021 - 2025
- WA State Medical License 2017 - 2025
- DC State Medical License 2015 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CCRF Emerging Scientist Award Children's Cancer Research Fund, 2022
Clinical Trials
- Combination Therapy for the Treatment of Diffuse Midline Gliomas Start of enrollment: 2021 Oct 20
Roles: Contact
Publications & Presentations
PubMed
- 80 citationsIntraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang, Kristy Seidel, Christopher Brown
Cancer Discovery. 2023-01-09 - 3 citationsA Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.Scott Boop, David Bonda, Stephanie Randle, Sarah Leary, Nicholas Vitanza
Pediatric Neurosurgery. 2023-01-01 - 22 citationsChildren with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.Erin E. Crotty, Sarah Leary, J. Russell Geyer, James M. Olson, Nathan Millard
Journal of Neuro-Oncology. 2020-06-16
Journal Articles
- Considerations when treating high-grade pediatric glioma patients with immunotherapy.Crotty E, Downey K, Ferrerosa L, Flores C, Hegde B, Raskin S, Hwang E, Vitanza N, Okada H, Expert Review of Neurotherapeutics, 12/17/2020
Grant Support
- CCRF 2022 Emerging Scientist AwardChildren's Cancer Research Fund2022–2023
- Clinical Research Scholar ProgramSeattle Children's Research Institute2021–2023
- Immune Priming Pediatric Brain TumorsThe Childhood Brain Tumor Foundation (CBTF)2020–2022
Professional Memberships
- Member
- Society for Neuro-OncologyMember
External Links
- Seattle Children's Brain Tumor Programhttps://www.seattlechildrens.org/conditions/brain-tumors/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: